Bio-Rad Laboratories, Inc. (BIO) stock
BIONYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO.B
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/3060% above fair value
$370.17+11.98 (+3.34%)
Close on Nov 18, 2026Market cap $10.00BP/E 45.3Yield –
Bio-Rad Laboratories pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Bio-Rad Laboratories's pe ratio was 46.8× on Nov 11, 2026, against 25.4× a year earlier. Over the last 5 years it ranged from 2.7× to 53.6×, with a median of 9.4×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 46.8× | +19.5 |
| 2025 | Oct 31, 2025 | 27.2× | +23.6 |
| 2022 | Apr 29, 2022 | 3.6× | +0.2 |
| 2021 | Dec 31, 2021 | 3.4× | −1.6 |
| 2020 | Dec 31, 2020 | 5.0× | −25.4 |
| 2019 | Dec 31, 2019 | 30.4× | +24.9 |
| 2018 | Dec 31, 2018 | 5.5× | −345.5 |
| 2017 | Dec 29, 2017 | 351.0× | +293.8 |
| 2016 | Dec 30, 2016 | 57.1× | +17.6 |
| 2015 | Dec 31, 2015 | 39.5× | −4.3 |
| 2014 | Dec 31, 2014 | 43.8× | +4.1 |
| 2013 | Dec 31, 2013 | 39.7× | +23.2 |
| 2012 | Dec 31, 2012 | 16.5× | +2.0 |
| 2011 | Dec 30, 2011 | 14.6× | −4.2 |
| 2010 | Dec 31, 2010 | 18.8× | −11.0 |
| 2009 | Dec 31, 2009 | 29.8× | – |
See a number that looks wrong?